Methods of Paraclinic Diagnosis of Catecholamine Secreting Tumours, Especially of Pheochromocytoma

Mitu, Florin; Maștaleru, Alexandra; Cojocaru, Clementina; Roca, Mihai; Mitu, Ovidiu; Leon-Constantin, Maria-Magdalena

doi:10.2478/inmed-2018-0012

References

1. Fliedner SMJ, Brabant G, Lehnert H. Pheochromocytoma and paraganglioma: genotype versus anatomic location as determinants of tumor phenotype. Cell Tissue Res. 2018 Jan 24. doi: 10.1007/s00441-017-2760-3.10.1007/s00441-017-2760-329362886
Open DOI Search in Google Scholar Back to article
2. Constantin Dumitrache. Endocrinologie clinica. Editura Naţional, 2012. pag 533-534.
Search in Google Scholar Back to article
3. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011;40(2):295-311.10.1016/j.ecl.2011.02.002309454221565668
Open DOI Search in Google Scholar Back to article
4. Bausch B, Tischler AS, Schmid KW et al. Max Schottelius: Pioneer in Pheochromocytoma. J Endocr Soc. 2017;1(7):957-964.10.1210/js.2017-00208568915029264546
Search in Google Scholar Back to article
5. Zbranca E. Ghid de diagnostic şi tratament în bolile endocrine, Ed. a III-a, Editura Polirom, 2008.
Search in Google Scholar Back to article
6. PDQ Adult Treatment Editorial Board. Pheochromocytoma and Paraganglioma Treatment (PDQ®): Health Professional Version. 2018 Feb 8. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002.
Search in Google Scholar Back to article
7. Lenders JWM, Eisenhofer G. Update on Modern Management of Pheochromocytoma and Paraganglioma. Endocrinol Metab (Seoul). 2017;32(2):152-161.10.3803/EnM.2017.32.2.152550385928685506
Open DOI Search in Google Scholar Back to article
8. Van Berkel A, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol. 2014;170(3):R109-19.10.1530/EJE-13-088224347425
Search in Google Scholar Back to article
9. Raber W, Raffesberg W, Bischof M et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med. 2000;160(19):2957-63.10.1001/archinte.160.19.295711041903
Search in Google Scholar Back to article
10. Lenders JW, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427-34.10.1001/jama.287.11.142711903030
Search in Google Scholar Back to article
11. Grouzmann E, Drouard-Troalen L, Baudin E et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol. 2010;162(5):951-60.10.1530/EJE-09-099620142367
Search in Google Scholar Back to article
12. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069-79.10.1210/jc.2007-172017989126
Open DOI Search in Google Scholar Back to article
13. Zuber S,Wesley R, Prodanov T et al. Clinical utility of chromogranin A in SDHx-related paragangliomas. Eur J Clin Invest. 2014;44(4):365-71.10.1111/eci.1224524467715
Open DOI Search in Google Scholar Back to article
14. Eisenhofer G, Goldstein DS, Walther MM et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. J Clin Endocrinol Metab. 2003;88(6):2656-66.10.1210/jc.2002-03000512788870
Open DOI Search in Google Scholar Back to article
15. Ergin AB, Kennedy L, Hamrahian AH, Gupta M. The Cleveland Clinic Manual of Dynamic Endocrine Testing. Clonidine Suppression Test, 2015, pag 55-58.10.1007/978-3-319-13048-4_14
Search in Google Scholar Back to article
16. Eisenhofer G, Lenders JW, Siegert G et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48(11):1739-49.10.1016/j.ejca.2011.07.016337262422036874
Search in Google Scholar Back to article
17. Osinga TE, Xekouki P, Nambuba J et al. SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma. Horm Metab Res. 2016;48(4):247-50.10.1055/s-0035-156926526916530
Search in Google Scholar Back to article
18. Taïeb D, Pacak K. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma. Cell Tissue Res. 2018. doi: 10.1007/s00441-018-2791-94.10.1007/s00441-018-2791-94
Open DOI Search in Google Scholar Back to article
19. Willatt J, Chong S, Ruma JA, Kuriakose J. Incidental Adrenal Nodules and Masses: The Imaging Approach. Int J Endocrinol. 2015;2015:410185.10.1155/2015/410185442919526064109
Search in Google Scholar Back to article
20. Yeomans H, Calissendorff J, Volpe C, Falhammar H, Mannheimer B. Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study. BMC Endocr Disord. 2015;15:6.10.1186/s12902-015-0001-x437705325887139
Search in Google Scholar Back to article
21. Santhanam P, Treglia G, Ahima RS. Detection of brown adipose tissue by 18 F-FDG PET/CT in pheochromocytoma/paraganglioma: A systematic review. J Clin Hypertens (Greenwich). 2018. doi: 10.1111/jch.13228.10.1111/jch.13228803080529443440
Open DOI Search in Google Scholar Back to article

Methods of Paraclinic Diagnosis of Catecholamine Secreting Tumours, Especially of Pheochromocytoma

References

Paradigm

My account